CDKN2A and neoplasm: The ARF protein is a key activator of p53 tumour suppressor function, which acts by protecting p53 from degradation, and the INK4A protein blocks the promotion of cell proliferation by the cyclin-dependent kinases CDK4 and CDK6 [22].